دورية أكاديمية

MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma

التفاصيل البيبلوغرافية
العنوان: MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanoma
المؤلفون: Rodig, Scott J., Gusenleitner, Daniel, Jackson, Donald G., Gjini, Evisa, Giobbie-Hurder, Anita, Jin, Chelsea, Chang, Han, Lovitch, Scott B., Horak, Christine, Weber, Jeffrey S., Weirather, Jason L., Wolchok, Jedd D., Postow, Michael A., Pavlick, Anna C., Chesney, Jason, Hodi, F. Stephen
المساهمون: Funded by Bristol-Myers Squibb, NIH/NCI Cancer Center
المصدر: Science Translational Medicine ; volume 10, issue 450 ; ISSN 1946-6234 1946-6242
بيانات النشر: American Association for the Advancement of Science (AAAS)
سنة النشر: 2018
الوصف: Loss of membrane MHC class I protein expression in most of tumor cells in advanced melanomas predicts primary resistance to anti–CTLA-4, but not anti-PD1, treatment.
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1126/scitranslmed.aar3342
الإتاحة: https://doi.org/10.1126/scitranslmed.aar3342Test
رقم الانضمام: edsbas.7FE0E960
قاعدة البيانات: BASE